1 |
Cos, P., Vlietinck, A. J., Berghe, D. V. and Maes, L. 2006. Antiinfective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. J. Ethnopharmacol. 106:290-302.
DOI
|
2 |
Dean, R., Van Kan, J. A., Pretorius, Z. A., Hammond-Kosack, K. E., Di Pietro, A., Spanu, P. D., Rudd, J. J., Dickman, M., Kahmann, R., Ellis, J. and Foster, G. D. 2012. The Top 10 fungal pathogens in molecular plant pathology. Mol. Plant Pathol. 13:414-430.
DOI
|
3 |
Dehury, B., Sahu, M., Sarma, K., Sahu, J., Sen, P., Modi, M. K., Sharma, G. D., Choudhury, M. D. and Barooah, M. 2013. Molecular phylogeny, homology modeling, and molecular dynamics simulation of race-specific bacterial blight disease resistance protein (xa5) of rice: a comparative agriproteomics approach. OMICS 17:423-438.
DOI
|
4 |
Deslandes, L. and Rivas, S. 2012. Catch me if you can: bacterial effectors and plant targets. Trends Plant Sci. 17:644-655.
DOI
|
5 |
Dey, F. and Caflisch, A. 2008. Fragment-based de novo ligand design by multiobjective evolutionary optimization. J. Chem. Inf. Model 48:679-690.
DOI
|
6 |
Doucet-Personeni, C., Bentley, P. D., Fletcher, R. J., Kinkaid, A., Kryger, G., Pirard, B., Taylor, A., Taylor, R., Taylor, J., Viner, R., Silman, I., Sussman, J. L., Greenblatt, H. M. and Lewis, T. 2001. A structure-based design approach to the development of novel, reversible AChE inhibitors. J. Med. Chem. 44:3203-3215.
DOI
|
7 |
Duffy, B. C., Zhu, L., Decornez, H. and Kitchen, D. B. 2012. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series. Bioorg. Med. Chem. 20:5324-5342.
DOI
|
8 |
Dunn, M. F., Ramirez-Trujillo, J. A. and Hernandez-Lucas, I. 2009. Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis. Microbiology 155:3166-3175.
DOI
|
9 |
Durrant, D. J. and McCammon, J. A. 2010. Computer-aided drugdiscovery techniques that account for receptor flexibility. Curr. Opin. Pharmacol. 10:770-774.
DOI
|
10 |
Eisenberg, D., Luthy, R. and Bowie, J. U. 1997. VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol. 277:396-406.
|
11 |
El Zoeiby, A., Sanschagrin, F. and Levesque, R. C. 2003. Structure and function of the Mur enzymes: development of novel inhibitors. Mol. Microbiol. 47:1-12.
|
12 |
Eswar, N., Webb, B., Marti-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U. and Sali, A. 2006. Comparative protein structure modeling using modeller. Curr. Protoc. Bioinformatics Chapter 5:Unit-5.6.
|
13 |
Feil, H., Feil, W. S., Chain, P., Larimer, F., DiBartolo, G., Copeland, A., Lykidis, A., Trong, S., Nolan, M., Goltsman, E., Thiel, J., Malfatti, S., Loper, J. E., Lapidus, A., Detter, J. C., Land, M., Richardson, P. M., Kyrpides, N. C., Ivanova, N. and Lindow, S. E. 2005. Comparison of the complete genome sequences of Pseudomonas syringae pv. syringae B728a and pv. tomato DC3000. Proc. Natl. Acad. Sci. U.S.A. 102:11064-11069.
DOI
|
14 |
Han, R., Zhang, J., Li, S., Cao, S., Geng, H., Yuan, Y., Xiao, W., Liu, S. and Liu, D. 2010. Homology modeling and screening of new -demethylase inhibitor (DMI) fungicides based on optimized expression of CYP51 from Ustilago maydis in Escherichia coli. J. Agric. Food Chem. 58:12810-12816.
DOI
|
15 |
Ferreira, L. G., Dos Santos, R. N., Oliva, G. and Andricopulo, A. D. 2015. Molecular docking and structure-based drug design strategies. Molecules 20:13384-13421.
DOI
|
16 |
Franceschetti, M., Maqbool, A., Jimenez-Dalmaroni, M. J., Pennington, H. G., Kamoun, S. and Banfield, M. J. 2017. Effectors of filamentous plant pathogens: commonalities amid diversity. Microbiol. Mol. Biol. Rev. 81:e00066-16.
|
17 |
Gao, Y. M., Wang, X. J., Zhang, J., Li, M., Liu, C. X., An, J., Jiang, L. and Xiang, W. S. 2012. Borrelidin, a potent antifungal agent: insight into the antifungal mechanism against Phytophthora sojae. J. Agric. Food Chem. 60:9874-9881.
DOI
|
18 |
Geppert, H., Vogt, M. and Bajorath, J. 2010. Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation. J. Chem. Inf. Model 50:205-216.
DOI
|
19 |
Goodford, P. J. 1985. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28:849-857.
DOI
|
20 |
Hanessian, S., Lu, P. P., Sanceau, J. Y., Chemla, P., Gohda, K., Fonne-Pfister, R., Prade, L. and Cowan-Jacob, S. W. 1999. An enzyme-bound bisubstrate hybrid inhibitor of adenylosuccinate synthetase. Angew. Chem. Int. Ed. 38:3159-3162.
DOI
|
21 |
Hughes, J. P., Rees, S. S., Kalindjian, S. B. and Philpott, K. L. 2011. Principles of early drug discovery. Br. J. Pharmacol. 162:1239-1249.
DOI
|
22 |
Hansch, C. 1969. A quantitative approach to biochemical structure-activity relationships. Acc. Chem. Res. 2:232-239.
DOI
|
23 |
Hansch, C. and Fujita, T. 1964. p- - Analysis. A method for the correlation of biological activity and chemical structure. J. Am. Chem. Soc. 86:1616-1626.
DOI
|
24 |
Hentschel, U., Steinert, M. and Hacker, J. 2000. Common molecular mechanisms of symbiosis and pathogenesis. Trends Microbiol. 8:226-231.
DOI
|
25 |
Herron, S. R., Benen, J. A., Scavetta, R. D., Visser, J. and Jurnak, F. 2000. Structure and function of pectic enzymes: virulence factors of plant pathogens. Proc. Natl. Acad. Sci. U.S.A. 97:8762-8769.
DOI
|
26 |
Huang, S. Y. and Zou, X. 2010. Advances and challenges in protein-ligand docking. Int. J. Mol. Sci. 11:3016-3034.
DOI
|
27 |
Imam, J., Singh, P. K. and Shukla, P. 2016. Plant microbe interactions in post genomic era: perspectives and applications. Front. Microbiol. 7:1488.
|
28 |
Jain, V., Sharma, A., Singh, G., Yogavel, M. and Sharma, A. 2017. Structure-based targeting of orthologous pathogen proteins accelerates antiparasitic drug discovery. ACS Infect. Dis. 3:281-292.
DOI
|
29 |
Jovanovic, M., James, E. H., Burrows, P. C., Rego, F. G., Buck, M. and Schumacher, J. 2011. Regulation of the co-evolved HrpR and HrpS AAA+ proteins required for Pseudomonas syringae pathogenicity. Nat. Commun. 2:177.
DOI
|
30 |
Kalyaanamoorthy, S. and Chen, Y. P. P. 2011. Structure-based drug design to augment hit discovery. Drug Discov. Today 16:831-839.
DOI
|
31 |
Kandakatla, N. and Ramakrishnan, G. 2014. Ligand based pharmacophore modeling and virtual screening studies to design novel HDAC2 inhibitors. Adv. Bioinformatics 2014:812148.
|
32 |
Kapetanovic, I. M. 2008. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem. Biol. Interact. 171:165-176.
DOI
|
33 |
Katiyar, C., Gupta, A., Kanjilal, S. and Katiya, S. 2012. Drug discovery from plant sources: an integrated approach. Ayu 33:10-19.
DOI
|
34 |
Mole, B. M., Baltrus, D. A., Dangl, J. L. and Grant, S. R. 2007. Global virulence regulation networks in phytopathogenic bacteria. Trends Microbiol. 15:363-371.
DOI
|
35 |
Laskowski, R. A., MacArthur, M. W., Moss, D. S. and Thornton, J. M. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26:283-291.
DOI
|
36 |
Lipinski, C. A., Lombardo, F., Dominy, B. W. and Feeney, P. J. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:3-25.
DOI
|
37 |
Liu, L., Qu, J., Li, D., Long, G. and Deng, Z. 2012. In silico characterization and molecular modeling of GntR family regulators in Xanthomonas axonopodis pv. citri: Implications for primary metabolism or virulence. Plant Omics 5:494-502.
|
38 |
Mansfield, J., Genin, S., Magori, S., Citovsky, V., Sriariyanum, M., Ronald, P., Dow, M. A. X., Verdier, V., Beer, S. V., Machado, M. A., Toth, I. A. N., Salmond, G. and Foster, G. D. 2012. Top 10 plant pathogenic bacteria in molecular plant pathology. Mol. Plant. Pathol. 13:614-629.
DOI
|
39 |
McInnes, C. 2007. Virtual screening strategies in drug discovery. Curr. Opin. Chem. Biol. 11:494-502.
DOI
|
40 |
Oprea, T. I. and Matter, H. 2004. Integrating virtual screening in lead discovery. Curr. Opin. Chem. Biol. 8:349-358.
DOI
|
41 |
Pathak, R. K., Taj, G., Pandey, D., Kasana, V. K., Baunthiyal, M. and Kumar, A. 2016. Molecular modeling and docking studies of phytoalexin(s) with pathogenic protein(s) as molecular targets for designing the derivatives with anti-fungal action on 'Alternaria' spp. of 'Brassica'. Plant Omics 9:172-182.
DOI
|
42 |
Pitzschke, A. and Hirt, H. 2010. New insights into an old story: Agrobacterium-induced tumour formation in plants by plant transformation. EMBO J. 29:1021-1032.
DOI
|
43 |
Schwede, T. 2013. Protein modeling: What happened to the "protein structure gap"? Structure 21:1531-1540.
DOI
|
44 |
Ramakrishnan, J., Rathore, S. S. and Raman, T. 2016. Review on fungal enzyme inhibitors-potential drug targets to manage human fungal infections. RSC Adv. 6:42387-42401.
DOI
|
45 |
Rarey, M., Kramer, B., Lengauer, T. and Klebe, G. 1996. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 261:470-489.
DOI
|
46 |
Rost, B. 1999. Twilight zone of protein sequence alignments. Protein Eng. 12:85-94.
DOI
|
47 |
Rost, B. and Sander, C. 1996. Bridging the protein sequencestructure gap by structure predictions. Annu. Rev. Biophys. Biomol. Struct. 25:113-136.
DOI
|
48 |
Sagatova, A. A., Keniya, M. V., Wilson, R. K., Monk, B. C. and Tyndall, J. D. 2015. Structural insights into binding of the antifungal drug fluconazole to Saccharomyces cerevisiae lanosterol -demethylase. Antimicrob. Agents Chemother. 59:4982-4989.
DOI
|
49 |
Siegel, M. R. 1981. Sterol-inhibiting fungicides: effects on sterol biosynthesis and sites of action. Plant Dis. 65:986-989.
DOI
|
50 |
Singh, D. B. 2014. Success, limitation and future of computer aided drug designing. Transl. Med. (Sunnyvale) 4:e127.
|
51 |
Sliwoski, G., Kothiwale, S., Meiler, J. and Lowe, E. W. 2013. Computational methods in drug discovery. Pharmacol. Rev. 66:334-395.
DOI
|
52 |
Soundararajan, P., Sakkiah, S., Sivanesan, I., Lee, K. W. and Jeong, B. R. 2011. Macromolecular docking simulation to identify binding site of FGB1 for antifungal compounds. Bull. Korean Chem. Soc. 32:3675-3681.
DOI
|
53 |
Strange, R. N. and Scott, P. R. 2005. Plant disease: a threat to global food security. Annu. Rev. Phytopathol. 43:83-116.
DOI
|
54 |
Tomasic, T., Sink, R., Zidar, N., Fic, A., Contreras-Martel, C., Dessen, A., Patin, D., Blanot, D., Muller-Premru, M., Gobec, S., Zega, A., Kikelj, D. and Masic, L. P. 2012. Dual inhibitor of MurD and MurE ligases from Escherichia coli and Staphylococcus aureus. ACS Med. Chem. Lett. 3:626-630.
DOI
|
55 |
Takano, Y., Kikuchi, T., Kubo, Y., Hamer, J. E., Mise, K. and Furusawa, I. 2000. The Colletotrichum lagenarium MAP kinase gene CMK1 regulates diverse aspects of fungal pathogenesis. Mol. Plant-Microbe Interact. 13:374-383.
DOI
|
56 |
Talele, T. T., Khedkar, S. A. and Rigby, A. C. 2010. Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. Curr. Top. Med. Chem. 10:127-141.
DOI
|
57 |
Taylor, D. 2015. the pharmaceutical industry and the future of drug development. In: Pharmaceuticals in the environment, eds. by R. E. Hester and R. M. Harrison, pp. 1-33. The Royal Society of Chemistry, London.
|
58 |
Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I. and Mackerell, A. D. 2010. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31:671-690.
|
59 |
Walter, M. W. 2002. Structure-based design of agrochemicals. Nat. Prod. Rep. 19:278-291.
DOI
|
60 |
Weigelt, J. 2010. Structural genomics-impact on biomedicine and drug discovery. Exp. Cell Res. 316:1332-1338.
DOI
|
61 |
Wride, D. A., Pourmand, N., Bray, W. M., Kosarchuk, J. J., Nisam, S. C., Quan, T. K., Berkeley, R. F., Katzman, S., Hartzog, G. A., Dobkin, C. E. and Lokey, R. S. 2014. Confirmation of the cellular targets of benomyl and rapamycin using next-generation sequencing of resistant mutants in S. cerevisiae. Mol. Biosyst. 10:3179-3187.
DOI
|
62 |
Yang, S. Y. 2010. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov. Today 15:444-450.
DOI
|
63 |
Xue, Y., Shui, G. and Wenk, M. R. 2014. TPS1 drug design for rice blast disease in Magnaporthe oryzae. Springerplus 3:18.
DOI
|
64 |
Yakoby, N., Kobiler, I., Dinoor, A. and Prusky, D. 2000. pH regulation of pectate lyase secretion modulates the attack of Colletotrichum gloeosporioides on avocado fruits. Appl. Environ. Microbiol. 66:1026-1030.
DOI
|
65 |
Yang, G. F., Jiang, X. H., Ding, Y. and Yang, H. Z. 2002. Three dimentional quantitative structure-activity relationships of novel 2-heteroaryl-4-chromanone derivatives. Acta Chim. Sin. 60:134-138.
|
66 |
Zhou, Y., Chen, L., Hu, J., Duan, H., Lin, D., Liu, P., Meng, Q., Li, B., Si, N., Liu, C. and Liu, X. 2015. Resistance mechanisms and molecular docking studies of four novel QoI fungicides in Peronophythora litchii. Sci. Rep. 5:17466.
DOI
|
67 |
Baig, M. H., Ahmad, K., Roy, S., Ashraf, J. M., Adil, M., Siddiqui, M. H., Khan, S., Kamal, M. A., Provaznik, I. and Choi, I. 2016. Computer aided drug design: success and limitations. Curr. Pharm. Des. 22:572-81.
DOI
|
68 |
Colovos, C. and Yeates, T. O. 1993. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 2:1511-1519.
DOI
|
69 |
Adam, M. 2005. Integrating research and development: the emergence of rational drug design in the pharmaceutical industry. Stud. Hist. Philos. Biol. Biomed. Sci. 36:513-537.
DOI
|
70 |
Al-Hussaini, R. and Mahasneh, A. M. 2009. Microbial growth and quorum sensing antagonist activities of herbal plants extracts. Molecules 14:3425-3435.
DOI
|
71 |
Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N. and Bourne, P. E. 2000. The protein data bank. Nucleic Acids Res. 28:235-242.
DOI
|
72 |
Boch, J. and Bonas, U. 2010. Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu. Rev. Phytopathol. 48:419-436.
DOI
|
73 |
Bocsanczy, A. M., Nissinen, R. M., Oh, C.-S. and Beer, S. V. 2008. HrpN of Erwinia amylovora functions in the translocation of DspA/E into plant cells. Mol. Plant Pathol. 9:425-434.
DOI
|
74 |
Bohm, H. J. 1996. Current computational tools for de novo ligand design. Curr. Opin. Biotechnol. 7:433-436.
DOI
|
75 |
Cavasotto, C. N. and Phatak, S. S. 2009. Homology modeling in drug discovery: current trends and applications. Drug Discov. Today 14:676-683.
DOI
|
76 |
Bordas, B., Komives, T. and Lopata, A. 2003. Ligand-based computer-aided pesticide design. A review of applications of the CoMFA and CoMSIA methodologies. Pest Manag. Sci. 59:393-400.
DOI
|
77 |
Boucher, C. A., Barberis, P. A. and Demery, D. A. 1985. Transposon mutagenesis of Pseudomonas solanacearum: isolation of Tn5-induced avirulent mutants. Microbiology 131:2449-2457.
DOI
|
78 |
Boyd, L. A., Ridout, C., O'Sullivan, D. M., Leach, J. E. and Leung, H. 2013. Plant-pathogen interactions: disease resistance in modern agriculture. Trends Genet. 29:233-240.
DOI
|
79 |
Bratkovic, T., Lunder, M., Urleb, U. and Strukelj, B. 2008. Peptide inhibitors of MurD and MurE, essential enzymes of bacterial cell wall biosynthesis. J. Basic Microbiol. 48:202-206.
DOI
|
80 |
Cairns, T. C., Studholme, D. J., Talbot, N. J. and Haynes, K. 2016. New and improved techniques for the study of pathogenic fungi. Trends Microbiol. 24:35-50.
DOI
|
81 |
Chandler, D., Bailey, A. S., Tatchell, G. M., Davidson, G., Greaves, J. and Grant, W. P. 2011. The development, regulation and use of biopesticides for integrated pest management. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 366:1987-1998.
DOI
|
82 |
Chandra, N. 2011. Computational approaches for drug target identification in pathogenic diseases. Expert. Opin. Drug Disc. 6:975-979.
DOI
|
83 |
Chen, C. and Dickman, M. B. 2004. Dominant active Rac and dominant negative Rac revert the dominant active Ras phenotype in Colletotrichum trifolii by distinct signalling pathways. Mol. Microbiol. 51:1493-1507.
DOI
|
84 |
Cho, J. Y., Choi, G. J., Lee, S. W., Jang, K. S., Lim, H. K., Lim, C. H., Lee, S. O., Cho, K. Y. and Kim, J. C. 2006. Antifungal activity against Colletotrichum spp. of curcuminoids isolated from Curcuma longa L. rhizomes. J. Microbiol. Biotechnol. 16:280-285.
|